# Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

> **NCT00049062** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** anastrozole
- **DRUG:** gefitinib

## Key facts

- **NCT ID:** NCT00049062
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** — (—)
- **Last updated:** 2013-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00049062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00049062, "Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00049062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*